Literature DB >> 17978590

Sleep apnea and hypertension: prevalence in chronic kidney disease.

John J Sim1, Scott A Rasgon, Stephen F Derose.   

Abstract

The authors sought to evaluate the prevalence of hypertension (HTN) in patients with sleep apnea (SA) who had normal kidney function and in patients with SA and chronic kidney disease (CKD). It has not been determined whether there is an effect of interplay of SA and CKD on the prevalence of HTN. In this study, the diagnosis of CKD was established based on the glomerular filtration rate and the presence of proteinuria. SA and HTN were diagnosed based on International Classification of Diseases, Ninth Revision coding, Current Procedural Terminology coding, and medication use. Using the database of a large integrated health system, 434,388 patients aged 18 years and older with 2 or more years of continuous enrollment during January 2002 to December 2004 were analyzed. The HTN rate with SA alone was 51%, compared with 70.2% with SA and CKD. The overall prevalence of HTN was 28% in patients without CKD or SA. The prevalence ratio for HTN was 1.36 (95% confidence interval, 1.33-1.39) more prevalent in patients with SA and CKD compared with patients with SA without CKD. The high prevalence of HTN in patients with SA and CKD suggests the need for evaluation of SA in patients with concurrent HTN and CKD.

Entities:  

Mesh:

Year:  2007        PMID: 17978590      PMCID: PMC8412038          DOI: 10.1111/j.1524-6175.2007.07176.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  23 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study.

Authors:  F J Nieto; T B Young; B K Lind; E Shahar; J M Samet; S Redline; R B D'Agostino; A B Newman; M D Lebowitz; T G Pickering
Journal:  JAMA       Date:  2000-04-12       Impact factor: 56.272

3.  Obstructive sleep apnea as a risk factor for stroke and death.

Authors:  H Klar Yaggi; John Concato; Walter N Kernan; Judith H Lichtman; Lawrence M Brass; Vahid Mohsenin
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

4.  Neuropsychological effects of one-week continuous positive airway pressure treatment in patients with obstructive sleep apnea: a placebo-controlled study.

Authors:  W A Bardwell; S Ancoli-Israel; C C Berry; J E Dimsdale
Journal:  Psychosom Med       Date:  2001 Jul-Aug       Impact factor: 4.312

5.  Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study.

Authors:  P Lavie; P Herer; V Hoffstein
Journal:  BMJ       Date:  2000-02-19

6.  Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population.

Authors:  H Kraiczi; Y Peker; K Caidahl; A Samuelsson; J Hedner
Journal:  J Hypertens       Date:  2001-11       Impact factor: 4.844

7.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

8.  Association of atrial fibrillation and obstructive sleep apnea.

Authors:  Apoor S Gami; Gregg Pressman; Sean M Caples; Ravi Kanagala; Joseph J Gard; Diane E Davison; Joseph F Malouf; Naser M Ammash; Paul A Friedman; Virend K Somers
Journal:  Circulation       Date:  2004-07-12       Impact factor: 29.690

9.  Sleep apnea and hypertension. A population-based study.

Authors:  K M Hla; T B Young; T Bidwell; M Palta; J B Skatrud; J Dempsey
Journal:  Ann Intern Med       Date:  1994-03-01       Impact factor: 25.391

10.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

View more
  5 in total

1.  Pediatrics: Masked hypertension: a risk factor in children with CKD.

Authors:  Robert H Mak; George Bakris
Journal:  Nat Rev Nephrol       Date:  2010-03       Impact factor: 28.314

Review 2.  What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease?

Authors:  Yazan Khouri; Susan P Steigerwalt; Mershed Alsamara; Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

3.  Sleep apnea in early childhood associated with preterm birth but not small for gestational age: a population-based record linkage study.

Authors:  Camille H Raynes-Greenow; Ruth M Hadfield; Peter A Cistulli; Jenny Bowen; Hugh Allen; Christine L Roberts
Journal:  Sleep       Date:  2012-11-01       Impact factor: 5.849

4.  Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome.

Authors:  Husam M Abdel-Qadir; Shaan Chugh; Douglas S Lee
Journal:  Int J Nephrol       Date:  2011-05-18

Review 5.  Treatment strategies to prevent renal damage in hypertensive children.

Authors:  Piotr Czarniak; Aleksandra Zurowska
Journal:  Curr Hypertens Rep       Date:  2014-04       Impact factor: 5.369

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.